Medblend Pharmaceuticals

Medblend Pharmaceuticals is a private pharmaceutical company headquartered in Panchkula, Haryana, India, that specializes in the manufacturing, marketing, and distribution of a diverse range of pharmaceutical and nutraceutical products. Incorporated in April 2025, the company primarily operates through a PCD (Propaganda Cum Distribution) franchise model and provides third-party manufacturing services across India. Its extensive product portfolio covers multiple therapeutic segments, including gastroenterology, cardiovascular health, neurology, psychiatry, and oncology, with dosage forms spanning tablets, capsules, syrups, and injectables. Medblend emphasizes high manufacturing standards by partnering with WHO-GMP and ISO certified facilities to ensure the quality and safety of its medicines. The company aims to provide affordable healthcare solutions and comprehensive marketing support to its business partners and franchise holders. Led by directors Aman Antil and Sumit Chourasiya, Medblend Pharmaceuticals is positioned as a rapidly growing player in the Indian pharmaceutical distribution landscape.